Insulin resistance is an evolutionarily conserved physiological mechanism at the cellular level for protection against increased oxidative stress

BioEssays

Volumn 29, Issue 8, 2007, Pages 811-818

  Erol, Adnan ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CATALASE; FATTY ACID; GLUCOSE; INSULIN; INSULIN RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; TRANSCRIPTION FACTOR DAF 16; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR PDX 1;

CELL PROLIFERATION; CELL PROTECTION; DIABETES MELLITUS; ELECTRON TRANSPORT; ENERGY METABOLISM; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; LIFESTYLE MODIFICATION; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; CYTOPROTECTION; EVOLUTION; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; MITOCHONDRIA; MODELS, BIOLOGICAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 34547628891     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20618     Document Type: Review

References (39)

1. Puig O, Tijan R. 2005. Transcriptional feedback control of insulin receptor by dFOXO/FO XO1. Genes Dev 19:2435-2446.
2. Biddinger SB, Kahn CR. 2006. From mice to men: Insights into the insulin resistance syndromes. Annu Rev Physiol 68:123-158.
3. Reaven GM. 1988. Banting lecture: role of insulin resistance in human disease, Diabetes 37:1595-1607.
4. Schinner S, ScherbaumWA, Bornstein SR, Barthel A. 2005. Molecular mechanisms of insulin resistance. Diab Med 22:674-682.
5. Shepherd PR, Withers DJ, Siddle K. 1998. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 333:471-490.
6. Bernstein LM, Tsyrlina EV, Vasilyev DA, Poroshina TE, Kovalenko RG. 2005. The phenomenon of the switching of estrogen effects and joker fuction of glucose. Ann NY Acad Sci 1057:235-246.
7. Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820.
8. Rolo AP, Palmeira CM. 2006. Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212:167-178.
9. Jia X, Olson DJH, Ross ARS, Wu L. 2006. Structural and functional changes in human insulin induced by methylglyoxal. FASEB J 20:1555-1557.
10. Evans JL, Goldfine ID, Maddux A, Grodsky GM. 2002. Oxidative stres and stres-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endoc Rev 23:599-622.
11. Bloch-Damti A, Bashan N. 2005. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal 7:1553-1567.
12. Fridlyand LE, Philipson LH. 2006. Reactive species and early manifestation of insulin resistance in type 2 diabates. Diabetes Obes Metab 8:136-145.
13. Erol A. 2005. Retrograde regulation due to mitochondrial dysfunction may be an important mechanism for carcinogenesis. Med Hypotheses 65:525-529.
14. Liu Z, Butow RA. 2006. Mitochondrial retrograde signaling. 40:159-185.
15. Storz P. 2006. Reactive oxygen species-mediated mitochondria-to-nucleus signaling: A key to aging and radical-caused diseases. Sci STKE apr 25:re3.
16. Storz P, ouml, D, ppler H, Toker A. 2005. Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species. Mol Cell Biol 25:8520-8530.
17. Zhang W, Zheng S, Storz P, Min W. 2005. Protein kinase D specifically mediates apoptosis signal-regulating kinase 1-JNK signaling induced by H202 but not tumor necrosis factor. J Biol Chem 280:19036-19044.
18. Kaneto H, Nakatani Y, Kawamori D, Miayatsuka T, Matsuoka TA, et al. 2006. Role of oxidative stres, endoplasmic reticulum stres, c-Jun N-terminal kinase in pancreatic β-cell dysfunction and insulin resistance. Int J Biochem Cell Biol 38:782-793.
19. Wang MC, Bohmann D, Jasper H. 2005. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 121:115-125.
20. Erol A. 2007. JNK/FOXO may be key mechanistic pathway for the hormetic anti-aging. Med Hypotheses 68:923-924.
21. Accili D, Arden KC. 2004. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421-426.
22. Imea M, Fu Z, Yoshida A, Noguchi T, Kato H. 2003. Nutritional hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16. J Mol Endorinol 30:253-262.
23. Oh SW, Mukhopadhyay A, Svrzikapa N, Davis RJ, Tissenbaum FA. 2005. JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc Natl Acad Sci USA 102:4494-4499.
24. Matsumato M, Accili D. 2006. All roads lead to FoxO. Cell Metab 1:215-216.
25. Kawamori D, Kaneto H, Nakatani Y, Matsuoaka TA, Matsuhisa M, et al. 2006. The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J Biol Chem 281:1091-1098.
26. Okamato H, Hribal ML, Lin HV, Bennett WR, Ward A, et al. 2006. Role of the forkhead protein FoxO1 in β- cell compensation to insulin resistance J Clin Invest 116:775-782.
27. Puig O, Marr MT, Ruhf ML, Tijan R. 2003. Control of cell number by drosophila FOXO: downstream and feedback regulation of the insulin receptor pathway. Genes Dev 17:2006-2020.
28. Puig O, Tijan R. 2005. Transcriptional feedback control of insulin receptor by dFOXO/FO XO1. Genes Dev 19:2435-2446.
29. Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, Takekawa S, et al. 2004. Insulin/FoxO1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279:30817-30822.
30. King GL, Goodman AD, Buzney S, Moses A, Kahn CR. 1985. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75:1028-1036.
31. Stout RW, Bierman EL, Ross R. 1975. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 36:319-327.
32. Hsueh WA, Quiñones MJ. 2003. Role of endothelial dysfunction in insulin resistance. Am J Cardiol 92:10-17.
33. Bartke A. 2006. Long-lived Klotho mice: new insights into the roles of IGF-1 and insulin in aging. Trends Endocrinol Metab 17:33-35.
34. Yamamoto M, Clark JD, Pastor JV, Kuro-o M, et al. 2005. Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem 280:38029-38034.
35. Zhang Q, Carter EA, Ma BY, White M, Fischman AC, et al. 2005. Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation. Life Sci 77:3068-3077.
36. Horton W. 2003. Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy. Toxicology 189:75-88.
37. Tuomilehto J, Lindstron J, Eriksson J, Valle T, Hamalainen H, et al. 2001. Finnish Diabetes Prevention Study Group. Prevention of type-2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350.
38. Neel JV. 1999. The thrifty genotype in 1998. Nutr Rev 57:S2-S9.
39. Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, et al. 2007. Comparison of the Atkins, Zone, Ornish, and LEARN Diets for Change in Weight and Related Risk Factors Among Overweight Premenopausal Women. JAMA 297:969-977.